| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.33 | 0.001 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.003 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |